EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunomodulatory Mechanisms and Therapeutic Potential of Vitamin D in Immune Thrombocytopenia

Yucao Ma iD, Wenjing Yao iD, Haiyan Lang iD, Yuxin Cheng iD, Ruhua Ren iD, Yuecan Chen iD, Sitong Cheng iD, Shuo Sun iD, Qing Guo iD, Shana Chen iD

Journal of Immunology Research · 2025

DOI: 10.1155/jimr/5810208 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Immunology Research, 2025. Verfasst von Yucao Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China, bucm.edu.cn. Hauptthemen laut MEDLINE: Vitamin D, Purpura, Thrombocytopenic, Idiopathic, Vitamin D Deficiency, Blood Platelets. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In addition to its classical function in regulating phosphorus and calcium equilibrium, the immunoregulatory effects of vitamin D (VD) have increasingly drawn attention in recent investigations. A deficiency of VD has been associated with multiple autoimmune pathologies. Immune thrombocytopenia (ITP), a hemorrhagic disorder mediated by autoantibodies, manifests through accelerated platelet destruction accompanied by impaired platelet production. Accumulating evidence suggests that VD is intricately involved in ITP pathophysiology, with serum VD concentrations strongly associated with clinical symptoms, disease severity, and overall prognosis. However, the mechanisms underlying these associations remain incompletely understood, and the limited number of studies conducted thus far highlights the necessity for further investigation. This study reviews the correlation between VD and ITP, the immunological mechanisms through which VD regulates ITP, and the potential therapeutic value of VD supplementation in ITP management. Future multicenter clinical trials and mechanistic studies are warranted to develop novel therapeutic strategies for ITP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin DPurpura, Thrombocytopenic, IdiopathicVitamin D DeficiencyBlood PlateletsHumansAnimalsImmunomodulationAutoantibodies

Stichwörter der Autor:innen

ITPimmunomodulationreviewvitamin Dvitamin D receptor

Substanzen

Vitamin DAutoantibodies

Autor:innen und Institutionen

  • Department of Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China, bucm.edu.cn.
  • Department of Hematology, International Mongolian Hospital of Inner Mongolia, Inner Mongolia Autonomous Region, Hohhot, 010020, China.

ORCID-Profile: Yucao Ma, Wenjing Yao, Haiyan Lang, Yuxin Cheng, Ruhua Ren, Yuecan Chen, Sitong Cheng, Shuo Sun, Qing Guo, Shana Chen

Förderung

  • National Natural Science Foundation of China
  • Beijing University of Chinese Medicine

Zitieren

APA

Ma, Y., Yao, W., Lang, H., Cheng, Y., Ren, R., Chen, Y., Cheng, S., Sun, S., Guo, Q., & Chen, S. (2025). Immunomodulatory Mechanisms and Therapeutic Potential of Vitamin D in Immune Thrombocytopenia. Journal of Immunology Research. https://doi.org/10.1155/jimr/5810208

Vancouver

Ma Y, Yao W, Lang H, Cheng Y, Ren R, Chen Y, et al. Immunomodulatory Mechanisms and Therapeutic Potential of Vitamin D in Immune Thrombocytopenia. Journal of Immunology Research. 2025. doi:10.1155/jimr/5810208

BibTeX
@article{Ma2025,
  author = {Ma, Yucao and Yao, Wenjing and Lang, Haiyan and Cheng, Yuxin and Ren, Ruhua and Chen, Yuecan and Cheng, Sitong and Sun, Shuo and Guo, Qing and Chen, Shana},
  title = {Immunomodulatory Mechanisms and Therapeutic Potential of Vitamin D in Immune Thrombocytopenia},
  journal = {Journal of Immunology Research},
  year = {2025},
  doi = {10.1155/jimr/5810208}
}
Kostenlos starten →